M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer

Jingqin Lan(Tongji Hospital), Guihua Wang(Hengyang Academy of Agricultural Sciences), Zhenlin Hou(Sun Yat-sen University), Li Sun(Union Hospital), Lu Liu(Huazhong University of Science and Technology), Fuqing Hu(Tongji Hospital), Jing Wang(Shandong University), Feng Xu(Shanghai Jiao Tong University), Xianglin Yuan(Tongji Hospital), Xuelai Luo(Tongji Hospital), Junbo Hu(Tongji Hospital), Da Song(Huazhong University of Science and Technology), Wei Wu(Huazhong University of Science and Technology Hospital)
Cancer Research
November 6, 2018
10.1158/0008-5472.can-18-0014
Cited by 672

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
|Cell|2019|601
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
|Autophagy|2023|387
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350